{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:16:49Z","timestamp":1792189009607,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Pesquisas Ren\u00e9 Rachou"},{"name":"da Funda\u00e7\u00e3o Oswaldo Cruz"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jpsychires.2016.12.001","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T23:46:17Z","timestamp":1480808777000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms"],"prefix":"10.1016","volume":"87","author":[{"given":"Salvina Maria","family":"de Campos-Carli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Sobreira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Cardoso","family":"de Oliveira Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Bortolo","family":"de Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Pessoa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Ferretjans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ribeiro-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vin\u00edcius","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-5422","authenticated-orcid":false,"given":"Antonio Lucio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2016.12.001_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0960327113493305","article-title":"Inflammation and schizophrenia: alterations in cytokine levels and perturbation in antioxidative defense systems","volume":"33","author":"Al-Asmari","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0924-9338(97)86748-X","article-title":"Dsm-IH-R psychotic disorders: procedural validity of the Mini International Neuropsychiatric interview (MINI). Concordance and causes for discordance with the CIDI","volume":"13","author":"Amorim","year":"1998","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jnr.10372","article-title":"Functional expression of CCR2 by human fetal astrocytes","volume":"70","author":"Andjelkovic","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andr\u00e9asson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jpsychires.2013.05.032","article-title":"Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia","volume":"47","author":"Asevedo","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00029-2","article-title":"Validity study of the Brazilian version of the calgary depression scale for schizophrenia","volume":"32","author":"Bressan","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib10","doi-asserted-by":"crossref","first-page":"e8688","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jpsychires.2016.12.001_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signaling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.12.001_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2016.12.001_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.12.001_bib16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/npp.2010.75","article-title":"Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder","volume":"35","author":"Eggan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2007.06.001","article-title":"Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors","volume":"189","author":"Eisenstein","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09629350123895","article-title":"Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment","volume":"10","author":"Erba\u011fci","year":"2001","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2014.04.028","article-title":"Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia","volume":"156","author":"Ferretjans","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib20","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.brainresbull.2011.09.014","article-title":"Regulation of CCL2\/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of \u03b12 adrenergic receptors","volume":"86","author":"Hinojosa","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/138955711795906941","article-title":"Anti-Inflamatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?","volume":"11","author":"Kato","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2249.2005.02803.x","article-title":"Cannabinoid influence on cytokine profile in multiple sclerosis","volume":"140","author":"Katona","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Luiza-Silva","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2016.12.001_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB\u20822","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokines alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000339113","article-title":"Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat","volume":"19","author":"Rettori","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09540260902782802","article-title":"Cannabinoids and psychosis","volume":"21","author":"Sewell","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2009.09.004","article-title":"Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats","volume":"20","author":"Spano","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YCO.0000000000000153","article-title":"Schizophrenia and psychoneuroimmunology: an integrative view","volume":"28","author":"Sperner-Unterweger","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/875647939000600106","article-title":"Interpretation of the correlation coefficient: a basic review","volume":"1","author":"Taylor","year":"1990","journal-title":"J.\u00a0Diagn. Med. Sonogr."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2016.12.001_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","article-title":"Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment","volume":"206","author":"Urig\u00fcen","year":"2009","journal-title":"Psychopharmacol. Berl."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.12.001_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2014.07.017","article-title":"Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia","volume":"159","author":"Volk","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.12.001_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2012.02.013","article-title":"Monocyte chemoattractant protein-1 in schizophrenia: -2518A\/G genetic variant and protein levels in Armenian population","volume":"58","author":"Zakharyan","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.jpsychires.2016.12.001_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.12.001_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia","volume":"65","author":"Zhang","year":"2004","journal-title":"J.\u00a0Clin. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616307373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616307373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T01:28:38Z","timestamp":1656034118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616307373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":45,"alternative-id":["S0022395616307373"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.12.001","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}